Biotech giant Illumina will unwind takeover of cancer-screening company Grail

SAN DIEGO, Calif. (AP) - Biotech giant Illumina says it will undo its $7.1 billion purchase of the cancer-screening company Grail. The company lost legal battles with antitrust enf…